CDEK by Data4ThePeople

Sign in Sign up

← All organizations

InCarda Therapeutics

For profitWebsite ↗

Also known as: Chief Medical Officer at InCarda Therapeutics | InCarda Therapeutics Australia Pty Ltd. | InCarda Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Apr 26, 2022

Timeline

2000s

Jun 1, 2009
InCarda Therapeutics— Founded

Drugs by trial phase (1 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

flecainide

Indications

Studied for

Atrial Fibrillation

Recent trials (4)

NCT05039359Lead sponsorPhase 3Apr 26, 2022
NCT05039359Study directorPhase 3Apr 26, 2022
NCT03539302Study directorPhase 2May 29, 2018
NCT03539302Lead sponsorPhase 2May 29, 2018

Details

Founded: Palo Alto, CA, US Jun 1, 2009
Last known activity: Apr 26, 2022